MAPT and Alzheimer disease: Previous reports describe misdiagnosis of mutation carriers as early-onset AD, exemplified by Doran et al. (2016), where four family members initially presented with AD-like memory deficits; diagnoses were revised to FTD only after neuropathological confirmation of tauopathy and genetic identification of MAPT mutations.